Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 1, 2008, Pages

  Li, Xun ^a,b   Tang, Kang ^a   Xie, Bin ^a   Li, Shumin ^a   Rozanski, George J ^a,c,d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Electrical remodeling; Heart failure; Potassium channels; Transient outward potassium current

Indexed keywords

KV CHANNEL INTERACTING PROTEIN; MESSENGER RNA; OXIDOREDUCTASE; PROTEIN KCHIP2; SHAL POTASSIUM CHANNEL; THIOREDOXIN; UNCLASSIFIED DRUG; AURANOFIN; ISOTRETINOIN; KCNIP2 PROTEIN, RAT; POTASSIUM; PYRUVIC ACID; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL MEMBRANE POTENTIAL; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HEART MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATCH CLAMP; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; AURANOFIN; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HEART FAILURE; ISOTRETINOIN; KV CHANNEL-INTERACTING PROTEINS; MALE; MEMBRANE POTENTIALS; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PATCH-CLAMP TECHNIQUES; POTASSIUM; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHAL POTASSIUM CHANNELS; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS; VENTRICULAR REMODELING;

EID: 49849085845     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91446.2007     Document Type: Article

References (39)

1. + channels in mouse ventricular myocytes. Circ Res 96: 451-458, 2005.
2. Ago T, Sadoshima J. Thioredoxin and ventricular remodeling. J Mol Cell Cardiol 41: 762-773, 2006.
3. Armoundas AA, Wu R, Juang G, Marban E, Tomaselli GF. Electrical and structural remodeling of the failing ventricle. Pharmacol Ther 92: 213-230, 2001.
4. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 113: 484-490, 1985.
5. Costantini DL, Arruda EP, Agarwal P, Kim KH, Zhu Y, Zhu W, Lebel M, Cheng CW, Park CY, Pierce SA, Guerchicoff A, Pollevick GD, Chan TY, Kabir MG, Cheng SH, Husain M, Antzelevitch C, Srivastava D, Gross GJ, Hui CC, Backx PH, Bruneau BG. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123: 347-358, 2005.
6. El-Adawi Deng L, Tramontano A, Smith S, Mascareno E, Ganguly K, Casillo R, El-Sherif N. The functional role of the JAK-STAT pathway in post-infarction remodeling. Cardiovasc Res 57: 129-138, 2003.
7. Fernanades AP, Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.
8. Hess ML, Kukreja RC. Free radicals, calcium homeostasis, heat shock proteins, and myocardial stunning. Ann Thorac Surg 60: 760-766, 1995.
9. Holmgren A, Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 252: 199-208, 1995.
10. Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, Apstein CS, Liao R. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 109: 898-903, 2004.
11. Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: role of oxygen free radicals and potential therapy with antioxidants. Am J Cardiol 73: 2B-7B, 1994.
12. + channel gene in cardiac myocytes and PC12 cells. Cardiovasc Res 60: 278-287, 2003.
13. Jia Y, Takimoto K. Mitogen-activated protein kinases control KChIP2 gene expression. Circ Res 98: 386-393, 2006.
14. Jung CH, Thomas JA. S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione. Arch Biochem Biophys 335: 61-72, 1996.
15. to remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288: H1417-H1424, 2005.
16. Liang H, Li X, Li S, Zheng MQ, Rozanski GJ. Oxidoreductase regulation of Kv currents in rat ventricle. J Mol Cell Cardiol. 44: 1062-1071, 2008.
17. Mallet RT. Pyruvate: metabolic protector of cardiac performance. Proc Soc Exp Biol Med 223: 136-148, 2000.
18. Mallet RT, Sun J. Antioxidant properties of myocardial fuels. Mol Cell Biochem 253: 103-111, 2003.
19. Miyamoto M, Kishimoto C, Shioji K, Nakamura H, Toyokumi S, Nakayama Y, Kita M, Yodoi J, Sasayama S. Difference in thioredoxin expression in viral myocarditis in inbred strains of mice. Jpn Circ J 65: 561-564, 2001.
20. Nerbonne JM, Kass RS. Physiology and molecular biology of ion channels contributing to ventricular repolarization. In: Cardiac Repolarization: Bridging Basic and Clinical Science, edited by Gussak I, Antzelevitch C, Hammill SC, Shen WK, and Bjerregaard P. Totowa, NJ: Humana, 2003, p. 25-62.
21. Nimata M, Kishimoto C, Shioji K, Ishizaki K, Kitaguchi S, Hashimoto T, Nagata N, Kawai C. Upregulation of redox-regulating protein, thioredoxin, in endomyocardial biopsy samples of patients with myocarditis and cardiomyopathies. Mol Cell Biochem 248: 193-196, 2003.
22. to) in normal and diseased myocardium. J Mol Cell Cardiol 33: 851-872, 2001.
23. Paget MS, Buttner MJ. Thiol-based regulatory switches. Annu Rev Genet 37: 91-121, 2003.
24. Powis G, Mustacichi D, Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312-322, 2000.
25. Raghavachari N, Lou MF. Evidence for the presence of thioltransferase in the lens. Exp Eye Res 63: 433-441, 1996.
26. + current of ventricular myocytes in rats with chronic myocardial infarction. Am J Physiol Heart Circ Physiol 274: H259-H265, 1998.
27. + channel remodeling. Clin Exp Pharmacol Physiol 29: 132-137, 2002.
28. + channel remodeling in postinfarction rat heart. Am J Physiol Heart Circ Physiol 282: H2346-H2355, 2002.
29. Rundlöf AK, Arnér ES. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid Redox Signal 6: 41-52, 2004.
30. Shioji K, Kishimoto C, Nakamura H, Toyokuni S, Nakayama Y, Yodoi J, Sasayama S. Upregulation of thioredoxin (TRX) expression in giant cells myocarditis in rats. FEBS Lett 472: 109-113, 2000.
31. Singal PK, Khaper N, Palance V, Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 40: 426-432, 1998.
32. Stadtman ER. Protein oxidation and aging. Free Radic Res 40: 1250-1258, 2006.
33. Takimoto K, Yang EK, Conforti L. Palmitoylation of KChIP splicing variants is required for efficient cell surface expression of Kv4.3 channels. J Biol Chem 277: 26904-26911, 2002.
34. Wang Y, De Keulenaer GW, Lee RT. Vitamin D3-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 277: 26496-26500, 2002.
35. Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI, Backx PH. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res 37: 312-323, 1998.
36. + channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 53: 80-88, 2002.
37. Yamawaki H, Haendeler J, Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 93: 1029-1033, 2003.
38. Yoshioka J, Schulze PC, Cupesi M, Sylvan JD, MacGillivray C, Gannon J, Huang H, Lee RT. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 109: 2581-2586, 2004.
39. Zhang TT, Takimoto K, Stewart AF, Zhu C, Levitan ES. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res 88: 476-482, 2001.